Pages that link to "Q48334805"

The following pages link to The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma (Q48334805):

Displaying 25 items.

• Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study (Q28943366) (← links)
• Survival and low-grade glioma: the emergence of genetic information (Q30395017) (← links)
• Inherited predisposition to glioma. (Q30477902) (← links)
• A functional +61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians (Q31076984) (← links)
• Association between EGF +61 G/A and glioma risk in a Chinese population (Q33582843) (← links)
• Genetic variations in VEGF and VEGFR2 and glioblastoma outcome (Q33781960) (← links)
• Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival (Q33897620) (← links)
• Genetic variations in EGF and EGFR and glioblastoma outcome (Q34133046) (← links)
• EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients (Q35146143) (← links)
• Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis (Q35150484) (← links)
• EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis (Q35569862) (← links)
• A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome (Q36948334) (← links)
• Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival (Q37177879) (← links)
• Molecular epidemiology of primary brain tumors (Q37533615) (← links)
• Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma (Q38104290) (← links)
• Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor (Q38937209) (← links)
• Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma (Q39000877) (← links)
• EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. (Q39021976) (← links)
• Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma (Q43863675) (← links)
• Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy (Q48581285) (← links)
• Association between +61G Polymorphism of the EGF Gene and Glioma Risk in Different Ethnicities: A Meta-Analysis (Q53077354) (← links)
• Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. (Q53334675) (← links)
• Association between Epidermal Growth Factor +61 G/A Polymorphism and Glioma Risk in a Chinese Han Population (Q55463424) (← links)
• The EGF 61A/G polymorphism – a predictive marker for recurrence of liver metastases from colorectal cancer (Q61842072) (← links)
• Association between EGF promoter polymorphisms and cancer risk: a meta-analysis (Q82335585) (← links)